Diabetic Papillopathy in Type Ii Diabetic Patients

Bayraktar, Zerrin; Alacali, Nilay; Bayraktar, Şükrü

doi:10.1097/00006982-200212000-00011

Cited by 59 publications

(61 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Conforme relatos atuais, a papilopatia diabética pode atuar como fator prognóstico (8) , e embora existam relatos substanciais de bom prognóstico em relação a preservação da acuidade e campo visual, acredita-se que a triancinolona possa atuar como mediador de limitação de tempo de evolução desta entidade, pelas suas propriedades anti-inflamatória e estabilizadora de perfusão capilar (9)(10) . No caso relatado, apesar de haver uma melhora anatômico-visual após um período relativamente longo de 8 meses, houve mais precocemente uma melhora da acuidade visual logo após 30 dias da segunda aplicação da triancinolona intravítrea.…”

Section: Discussionunclassified

Papilopatia diabética e triamcinolona intravítrea

Damasceno¹,

Damasceno²,

Horowitz³

et al. 2008

Rev. bras.oftalmol.

View full text Add to dashboard Cite

RESUMOOs autores descrevem um caso de papilopatia diabética em paciente diabética insulinodependente no qual se utilizou o acetonido de triancinolona com injeção intravítrea como opção de tratamento.Descritores: Acetonido de triancinolona/uso terapêutico; Papiledema/quimioterapia; Papiledema/etiologia; Diabetes mellitus/complicações, Acuidade visual; Relatos de casos [Tipo de publicação]

show abstract

Section: Discussionunclassified

Papilopatia diabética e triamcinolona intravítrea

Damasceno¹,

Damasceno²,

Horowitz³

et al. 2008

Rev. bras.oftalmol.

View full text Add to dashboard Cite

show abstract

“…6 Visual field defects included enlarged blind spots, generalized constriction, and arcuate scotomas. 3,6,7 Disc oedema was often diffuse with hyperoemia. Diabetic papillopathy was considered one form of nonarteritic anterior ischaemic optic neuropathy, with special characteristics: long duration of disc oedema, mild to-moderate initial visual loss, relatively mild-to- moderate optic nerve dysfunction, and good visual recovery.…”

Section: Discussionmentioning

confidence: 99%

“…6 Several patients in the present study had poor initial visual acuity. More than 30% of reported patients with diabetic papillopathy 3,6,7,16,17 (16 out of 52 patients) had initial visual acuities below or equal to 6/30 as follows: two patients had 6/30, eight patients had 6/60, and six patients had less than 6/60.…”

Section: Discussionmentioning

confidence: 99%

“…Diabetic papillopathy lasted several months, and resolved with mild to moderate visual loss. 3,6,7 Periocular corticosteroids were used to treat intermediate or posterior uveitis, 8 optic disc neovascularization from chronic uveitis, 9 rubeosis iridis, 10 cystoid macular oedema, 11 and arteritic ischaemic optic neuropathy. 12 We investigated the effect of periocular corticosteroids on the duration of diabetic papillopathy.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Periocular corticosteroids in diabetic papillopathy

Mansour

El-Dairi

Shehab

et al. 2004

Eye

View full text Add to dashboard Cite

Purpose To ascertain the therapeutic effect of periocular corticosteroids in diabetic papillopathy. Methods Prospectively, five consecutive adult-onset diabetic patients with symptomatic diabetic papillopathy underwent visual fields and fluorescein angiography before and after superonasal subtenon injection of corticosteroids. Results The median duration of papillopathy was 2.5 weeks by ophthalmoscopy and 3 weeks by fluorescein angiography. The median recovery time of best-spectaclecorrected visual acuity was 2 weeks. Two patients developed sequential diabetic papillopathy, and both reported faster visual recovery and better subjective vision in treated eyes. In these two patients, the final bestspectacle-corrected visual acuity and visual evoked responses were comparable between the two eyes, while automated visual fields were less constricted in treated eyes. Complications included ocular hypertension, mild progression of cataract, and mild ptosis in one patient each. Conclusions Periocular corticosteroids shortened the duration of diabetic papillopathy from a reported median of 5 months to 3 weeks in the present uncontrolled observational study, partly by their angiostatic and antioedema effects at the level of the anterior optic nerve. Intraocular pressure needs to be monitored in eyes receiving periocular corticosteroids.

show abstract

“…1-3 DP may occur in patients with type 1 diabetes mellitus (DM) 1 and type 2 DM, 2,3 with approximately a 0.5% incidence, 1 irrespective of metabolic control and severity of diabetic retinopathy. DP is a diagnosis of exclusion, made after other causes of disk swelling have been ruled out.…”

Section: Introductionmentioning

confidence: 99%

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab

Kim¹

2016

EJEA

View full text Add to dashboard Cite

Abstract:We report a case of diabetic papillopathy that demonstrated a resolution of optic disk swelling and rapid visual recovery when intravitreal ranibizumab was administered. A 51-year-old male presented with acute painless visual loss in his right eye. His vision was 20/320 in the right eye and 20/50 in the left eye. Fundus examination of the right eye showed nonproliferative diabetic retinopathy with macular edema and a swollen optic disk. Fluorescein angiography showed dye leakage from the right optic disk. Optical coherent tomography revealed a significant increase in retinal nerve fiber-layer thickness. Magnetic resonance imaging of the brain was normal. The patient received a single intravitreal ranibizumab (0.5 mg) injection. Two weeks following injection, there was marked regression of the disk swelling and improvement of macular edema, with vision improving to 20/100. Three months following injection, there was complete resolution of the optic disk swelling. No further treatment was required.

show abstract

Diabetic Papillopathy in Type Ii Diabetic Patients

Abstract: Diabetic papillopathy may be found in older patients with type II diabetes. Nonproliferative or proliferative diabetic retinopathy as well as macular edema may also be associated with this disorder.

Cited by 59 publications

References 18 publications

Papilopatia diabética e triamcinolona intravítrea

Papilopatia diabética e triamcinolona intravítrea

Periocular corticosteroids in diabetic papillopathy

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab

Contact Info

Product

Resources

About